Category Archives: journliasm-recent

“Torture, American-Style: The Role of Money in Interrogations,” Vanity Fair

A scathing new report reveals how the Defense Department and psychologists went in on what amounts to an “undisclosed joint venture.” Continue reading

Posted in home-page, journliasm-recent | Leave a comment

“The Psychologists Who Taught the C.I.A. How to Torture (and Charged $180 Million),” Vanity Fair

With the U.S. Senate Select Intelligence Committee’s release on Tuesday morning of the executive summary of its “torture report,” a five-year, $40 million probe into the C.I.A.’s use of extreme interrogation tactics, there should no longer be any doubt. The C.I.A. tortured detainees in ways more brutal, sustained, and gruesome than was previously known, and two medical professionals were integral to its efforts. Continue reading

Posted in home-page, journliasm-recent | Leave a comment

“Drug Shortages: The Scary Reality of a World Without Meds,” Reader’s Digest

Imagine surgeons running out of anesthetic drugs, cancer patients who can’t get lifesaving chemotherapy, and doctors scrambling for the most basic antibiotics. We’re already there. Continue reading

Posted in home-page, journliasm-recent | Leave a comment

“What ails Big Pharma,” Fortune Magazine

A new book chronicles the uneasy relationship between money and drugs, and what it means for the rest of us. Continue reading

Posted in home-page, journliasm-recent | Leave a comment

“Ranbaxy’s empty promises,” Fortune Magazine

On Jan. 23, the FDA dropped a heavy hammer on the Indian generic drug giant Ranbaxy Laboratories, announcing it will restrict imports from the company’s manufacturing plant in Toansa, India. It was the fourth Ranbaxy factory to be barred by the FDA since 2008. The move came after an unannounced inspection in early January turned up a devastating litany of infractions: a laboratory area littered with flies, a leaking refrigerator for drug samples, and evidence that laboratory technicians were altering data to improve test results. Continue reading

Posted in home-page, journliasm-recent | Leave a comment

“Painful prescription: Pharmacy benefit managers make out better than their customers,” Fortune Magazine

In late 2008, Meridian Health Systems, a nonprofit that owns and operates six hospitals in southern New Jersey, hired a new pharmacy benefits management (PBM) company to help reduce the surging medication costs for its 12,000 employees and their families. Express Scripts, which has since become the largest PBM in the country, projected that it would slice at least $763,000 from Meridian’s $12 million in annual drug spending. Continue reading

Posted in home-page, journliasm-recent | Leave a comment

“Why the Supreme Court is wrong on generic drugs,” Fortune.com

On Monday, in a 5-4 vote, the court ruled that since generic drugmakers are only replicating brand-name drugs that have already been deemed safe by the Food and Drug Administration, patients can’t sue to hold them liable for the dangerous design of a pharmaceutical. Continue reading

Posted in home-page, journliasm-recent, The latest | Leave a comment

“The latest to claim fraud at generic Lipitor maker Ranbaxy: Its owners,” Fortune.com

Japanese drugmaker Daiichi Sankyo has quietly stood by its decision to purchase Ranbaxy in 2008. Now, though, the company is publicly suggesting it was defrauded in the $4.6 billion acquisition. Continue reading

Posted in home-page, journliasm-recent, The latest | Leave a comment

“Dirty medicine: The epic inside story of fraud at a generic Lipitor giant,” Fortune Magazine

The epic inside story of long-term criminal fraud at Ranbaxy, the Indian drug company that makes generic Lipitor for millions of Americans. Continue reading

Posted in home-page, journliasm-recent, The latest | Leave a comment

“Maker of generic Lipitor pleads guilty to selling adulterated drugs” Fortune.com

Ranbaxy Laboratories pleads guilty to seven criminal counts.
Continue reading

Posted in journliasm-recent, The latest | Leave a comment